(S)-Di-Tert-Butyl 2-(3-((S)-6-Amino-1-(Tert-Butoxy)-1-Oxohexan-2-Yl)Ureido)Pentanedioate manufacturers
|
| (S)-Di-Tert-Butyl 2-(3-((S)-6-Amino-1-(Tert-Butoxy)-1-Oxohexan-2-Yl)Ureido)Pentanedioate Basic information |
Product Name: | (S)-Di-Tert-Butyl 2-(3-((S)-6-Amino-1-(Tert-Butoxy)-1-Oxohexan-2-Yl)Ureido)Pentanedioate | Synonyms: | (S)-Di-Tert-Butyl 2-(3-((S)-6-Amino-1-(Tert-Butoxy)-1-Oxohexan-2-Yl)Ureido)Pentanedioate;ditert-butyl (2S)-2-[[(2S)-6-amino-1-[(2-methylpropan-2-yl)oxy]-1-oxohexan-2-yl]carbamoylamino]pentanedioate;tert-Butyl-DCL (PSMA inhibitor);L-Glutamic acid, N-[[[(1S)-5-amino-1-[(1,1-dimethylethoxy)carbonyl]pentyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester;(S)-Di-Tert-Butyl 2-(3-((S)-6-Amino-1-(Tert-Butoxy)-1-Oxohexan-2-Yl)Ureido)Pentanedioate(WXC02272);min. 96%, min;(S)?-?DI-?TERT-?BUTYL 2-?(3-?((S)?-?6-?AMINO-?1-?(TERT-?BUTOXY)?-?1-?OXOHEXAN-?2-?YL)?UREIDO)?PENTANEDIOATE; MIN. 96?%, MIN;CS-0047390 | CAS: | 1025796-31-9 | MF: | C24H45N3O7 | MW: | 487.63 | EINECS: | | Product Categories: | | Mol File: | 1025796-31-9.mol | |
| (S)-Di-Tert-Butyl 2-(3-((S)-6-Amino-1-(Tert-Butoxy)-1-Oxohexan-2-Yl)Ureido)Pentanedioate Chemical Properties |
Boiling point | 596.6±50.0 °C(Predicted) | density | 1.072±0.06 g/cm3(Predicted) | pka | 12.09±0.46(Predicted) | form | Solid-Liquid Mixture | color | Colorless to off-white | InChIKey | IXWXFSGSTGXUFO-IRXDYDNUSA-N | SMILES | C(OC(C)(C)C)(=O)[C@H](CCC(OC(C)(C)C)=O)NC(N[C@H](C(OC(C)(C)C)=O)CCCCN)=O |
| (S)-Di-Tert-Butyl 2-(3-((S)-6-Amino-1-(Tert-Butoxy)-1-Oxohexan-2-Yl)Ureido)Pentanedioate Usage And Synthesis |
Uses | (S)-Di-tert-butyl 2-(3-((S)-6-Amino-1-(tert-butoxy)-1-oxohexan-2-yl)ureido)pentanedioate is used as a reactant in the synthesis of novel multivalent fluorescent inhibitors with high affinity to prostate cancer. |
| (S)-Di-Tert-Butyl 2-(3-((S)-6-Amino-1-(Tert-Butoxy)-1-Oxohexan-2-Yl)Ureido)Pentanedioate Preparation Products And Raw materials |
|